Clinical Trial Update: The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effect of a PPAR-alpha agonist on cytochrome P450 monooxygenase activity in hypertensive patients; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• PPAR-alpha agonist

Snippet

Sponsor: Vanderbilt University | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2013-06-20